Three-year outcomes of A Randomized Multicentre Trial Comparing Revascularization and Optimal Medical Therapy for Chronic Total Coronary Occlusions (EuroCTO)
EuroIntervention · 2023-09 · 19 (7) · 571-579
DOI: 10.4244/eij-d-23-00312 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift EuroIntervention, 2023-09. Verfasst von Gerald S Werner und 15 weiteren Autor:innen. Beteiligte Einrichtung: Klinikum Darmstadt GmbH, Darmstadt, Germany. Hauptthemen laut MEDLINE: Coronary Occlusion, Percutaneous Coronary Intervention, Myocardial Infarction. Die Arbeit wurde bisher 58-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
BACKGROUND: Percutaneous coronary intervention (PCI) for chronic total coronary occlusions (CTO) improves clinical symptoms and quality of life. The longer-term safety of PCI compared to optimal medical therapy (OMT) remains uncertain. AIMS: We sought to evaluate the long-term safety of PCI for CTO in a randomised trial as compared to OMT. METHODS: A total of 396 patients with a symptomatic CTO were enrolled into a randomised, multicentre clinical trial comparing PCI and OMT. Half of the patients had a single CTO; the others had multivessel disease. Non-CTO lesions were treated prior to randomisation (2:1 ratio). During follow-up, crossover from OMT to PCI occurred in 7.3% (1 year) and 17.5% (3 years) of patients. RESULTS: At 3 years, the incidence of cardiovascular death or nonfatal myocardial infarction was not significantly different between the groups (OMT 3.7% vs PCI 6.2%; p=0.29). By per-protocol analysis, the difference remained non-significant (OMT 5.7% vs PCI 4.7%; p=0.67). Overall, major adverse cardiovascular events (MACE) were more frequent with OMT (OMT 21.2% vs PCI 11.2%), largely because of ischaemia-driven revascularisation. The rates of stroke or hospitalisation for bleeding were not different between the groups. CONCLUSIONS: At 3 years there was no difference in the rate of cardiovascular death or myocardial infarction between PCI or OMT among patients with a remaining single coronary CTO. The MACE rate was higher in the OMT group due largely to ischaemia-driven revascularisation. CTO PCI appears to be a safe option for patients with a single remaining significant coronary CTO. CinicalTrials.gov: NCT01760083.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Klinikum Darmstadt GmbH, Darmstadt, Germany.
- Brighton and Sussex University Hospitals, Brighton, UK.
- Interventional Cardiology, CH Angoulême, Angoulême, France.
- Interventional Cardiology, Clinique Saint Augustin, Bordeaux, France.
- AHEPA University Hospital, Thessaloniki, Greece.
- MHAT Tokuda Hospital Sofia, Sofia, Bulgaria.
Zitieren
APA
Werner, G. S., Hildick-Smith, D., Martin Yuste, V., Boudou, N., Sianos, G., Gelev, V., Rumoroso, J. R., Erglis, A., Christiansen, E. H., Escaned, J., Di Mario, C., Teruel, L., Bufe, A., Lauer, B., Galassi, A. R., & Louvard, Y. (2023). Three-year outcomes of A Randomized Multicentre Trial Comparing Revascularization and Optimal Medical Therapy for Chronic Total Coronary Occlusions (EuroCTO). EuroIntervention, 19(7), 571-579. https://doi.org/10.4244/eij-d-23-00312
Vancouver
Werner GS, Hildick-Smith D, Martin Yuste V, Boudou N, Sianos G, Gelev V, et al. Three-year outcomes of A Randomized Multicentre Trial Comparing Revascularization and Optimal Medical Therapy for Chronic Total Coronary Occlusions (EuroCTO). EuroIntervention. 2023;19(7):571-579. doi:10.4244/eij-d-23-00312
BibTeX
@article{Werner2023,
author = {Werner, Gerald S and Hildick-Smith, David and Martin Yuste, Victoria and Boudou, Nicolas and Sianos, Georgios and Gelev, Valery and Rumoroso, Jose Ramon and Erglis, Andrejs and Christiansen, Evald Hoj and Escaned, Javier and Di Mario, Carlo and Teruel, Luis and Bufe, Alexander and Lauer, Bernward and Galassi, Alfredo Ruggero and Louvard, Yves},
title = {Three-year outcomes of A Randomized Multicentre Trial Comparing Revascularization and Optimal Medical Therapy for Chronic Total Coronary Occlusions (EuroCTO)},
journal = {EuroIntervention},
year = {2023},
volume = {19},
number = {7},
pages = {571--579},
doi = {10.4244/eij-d-23-00312}
}
EUVIMED